Chris Kontos

Corporate Officer/Principal bij Aerpio Therapeutics, Inc.

Health Technology

Oorsprong van het eerstegraads netwerk van Chris Kontos

Entiteit	Type entiteit	Industrie
Aerpio Therapeutics, Inc. Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. 8	Subsidiary	Pharmaceuticals: Major	8

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Chris Kontos via zijn persoonlijke netwerk

Onderneming	Sector	Gelieerde personen	Hoofdpost
AKEBIA THERAPEUTICS, INC.	Pharmaceuticals: Major	Anupam Dalal Joseph H. Gardner Kevin G. Peters	Director/Board Member Founder Chief Tech/Sci/R&D Officer
The University of California, San Francisco	College/University	Anupam Dalal Caley Castelein	Doctorate Degree Doctorate Degree
Aadi Subsidiary, Inc. Aadi Subsidiary, Inc. BiotechnologyHealth Technology Aadi Subsidiary, Inc. engages in biopharmaceutical company. Its therapeutic programs include pulmonary arterial hypertension, pediatric solid tumors, solid tumors with mTOR activation and mitochondrial disease. The company was founded by Neil Desai and is headquartered in Pacific Palisades, CA.	Biotechnology	Anupam Dalal Caley Castelein	Director/Board Member Chairman
Procter & Gamble Pharmaceuticals, Inc. Procter & Gamble Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Procter & Gamble Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its products include Actonel, Asacol, Enablex, Didronel, Macrobid, Macrodantin, Entex, and Ziac. The firm manufactures and markets a variety of over-the-counter and oral care products such as Crest, Oral-B, Prilosec OTC, Vicks, Metamucil, Pepto-Bismol, ThermaCare, and other related products. The company was founded in 1970 and is headquartered in Cincinnati, OH.	Pharmaceuticals: Major	Joseph H. Gardner Kevin G. Peters	Corporate Officer/Principal Chief Tech/Sci/R&D Officer
AADI BIOSCIENCE, INC.	Biotechnology	Anupam Dalal Caley Castelein	Director/Board Member Chairman
NewBridge Pharmaceuticals FZ LLC NewBridge Pharmaceuticals FZ LLC Pharmaceuticals: MajorHealth Technology NewBridge Pharmaceuticals FZ LLC engages in the manufacture and distribution of pharmaceutical products, therapeutics and medical devices. The company was founded by G. Garrett Vygantas in 2007 and is headquartered in Dubai, United Arab Emirates.	Pharmaceuticals: Major	Anupam Dalal Caley Castelein	Director/Board Member Director/Board Member
Kearny Venture Partners Kearny Venture Partners Investment ManagersFinance Kearny Venture Partners (Kearny Venture Partners) is a venture capital firm. The firm is headquartered in San Francisco, California.	Investment Managers	Anupam Dalal Caley Castelein	Private Equity Investor Private Equity Investor
MEDIVATION INC	Pharmaceuticals: Major	Cheryl Cohen	Corporate Officer/Principal
Tourmaline Bio, Inc. Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Tourmaline Bio, Inc., Tourmaline Sub, Inc. is a late-stage clinical biotechnology company based in New York, NY. The company's lead program, Tour006, is an anti-IL-6 antibody with high binding affinity and a naturally long half-life. Tour006 has been studied in over 400 autoimmune patients across six clinical trials. Tourmaline Sub plans to develop Tour006 for thyroid eye disease (TED) and atherosclerotic cardiovascular disease (ASCVD), with additional indications being considered. The company, founded in 2021 by Sandeep Kulkarni and Caley M. Castelein, is focused on developing transformative medicines for patients with life-altering immune diseases. Sandeep Kulkarni has been the CEO since 2021. Tourmaline Sub was acquired by Talaris Therapeutics, Inc. on October 19, 2023, for $43.50 million.	Miscellaneous Commercial Services	Caley Castelein	Founder
KVP Capital LP	Investment Trusts/Mutual Funds	Caley Castelein	Founder
Harvard College	College/University	Caley Castelein	Undergraduate Degree
Kearny Venture Partners LP Kearny Venture Partners LP Investment ManagersFinance Kearny Venture Partners LP invests in US healthcare companies operating in the fields of medical devices and drugs (small molecules & biopharmaceuticals). The fund invests in the range of $10 - $15 million per company with an initial investment of $2 - $8 million. It provides financing for seed, early & later-stage capital requirements.	Investment Managers	Caley Castelein	Founder
AliveCor, Inc. AliveCor, Inc. Packaged SoftwareTechnology Services AliveCor, Inc. develops mobile heart monitoring system. It offers kardia mobile that provides people with suspected or diagnosed heart conditions, and those at risk of heart conditions. The company was founded by David E. Albert, Bruce Satchwell, and Kim Barnett and is headquartered in San Francisco, CA.	Packaged Software	Caley Castelein	Director/Board Member
Waterstone Pharmaceuticals, Inc. Waterstone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Waterstone Pharmaceuticals, Inc. engages in the provision of discovery, development, and commercialization of innovative drugs for the treatment of liver and gastrointestinal diseases. The company was founded by Faming Zhang in 2008 and is headquartered in Carmel, IN.	Pharmaceuticals: Major	Caley Castelein	Director/Board Member
Wellpartner LLC Wellpartner LLC Medical DistributorsDistribution Services Wellpartner LLC engages in the provision of pharmacy services. It offers 340B program management. It provides a seamless, easy-to-use solution for covered entities currently or considering participating in the 340B Drug Program. The company was founded by Michael W. Wright and Robert Judge in November 1998 and is headquartered in Tualatin, OR.	Medical Distributors	Caley Castelein	Director/Board Member
VIEWRAY, INC.	Medical Specialties	Caley Castelein	Director/Board Member
JDRF International JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY.	Miscellaneous Commercial Services	Joseph H. Gardner	Director/Board Member
Tulane University (Louisiana)	College/University	Joseph H. Gardner	Undergraduate Degree
BRISTOL-MYERS SQUIBB COMPANY	Pharmaceuticals: Major	Kevin G. Peters	Chief Tech/Sci/R&D Officer
OCUPHIRE PHARMA, INC.	Pharmaceuticals: Major	Mitchell Brigell	Chief Tech/Sci/R&D Officer
Kansas State University	College/University	Mitchell Brigell	Doctorate Degree
Novartis Institutes of Biomedical Research Novartis Institutes of Biomedical Research BiotechnologyHealth Technology Novartis Institutes of Biomedical Research operates a pharmaceutical research organization. The private company is based in Emeryville.	Biotechnology	Mitchell Brigell	Corporate Officer/Principal
Augustana University	College/University	Kevin G. Peters	Undergraduate Degree
University of Iowa	College/University	Kevin G. Peters	Doctorate Degree
Duke University Medical Center	College/University	Kevin G. Peters	Corporate Officer/Principal
Thrombogenics, Inc. Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY.	Miscellaneous Commercial Services	Stephen Pakola	Chief Tech/Sci/R&D Officer
Utah State University	College/University	Joseph H. Gardner	Graduate Degree
REGENXBIO INC.	Pharmaceuticals: Major	Stephen Pakola	Chief Tech/Sci/R&D Officer
Amakem NV Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium.	Medical/Nursing Services	Stephen Pakola	Chief Tech/Sci/R&D Officer
University of Pennsylvania	College/University	Stephen Pakola	Doctorate Degree
Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT.	Pharmaceuticals: Major	Stephen Pakola	Corporate Officer/Principal
OXURION NV	Pharmaceuticals: Major	Stephen Pakola	Chief Tech/Sci/R&D Officer
University of Wisconsin	College/University	Joseph H. Gardner	Doctorate Degree
NEOS THERAPEUTICS, INC.	Pharmaceuticals: Major	Caley Castelein	Director/Board Member
Viewray Technologies, Inc. Viewray Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Viewray Technologies, Inc. develops radiation therapy technology for the treatment of cancer. It operates through the MRIdian system software. The company was founded by James F. Dempsey and Russell S. Donda in March 2004 and is headquartered in Oakwood Village, OH.	Miscellaneous Commercial Services	Caley Castelein	Director/Board Member
IMMUNITYBIO, INC.	Pharmaceuticals: Major	Cheryl Cohen	Director/Board Member
Centocor, Inc. Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA.	Medical Specialties	Cheryl Cohen	Corporate Officer/Principal
Saint Joseph College	College/University	Cheryl Cohen	Undergraduate Degree
LADRX CORPORATION	Biotechnology	Cheryl Cohen	Director/Board Member
Protein Sciences Corp. Protein Sciences Corp. BiotechnologyHealth Technology Protein Sciences Corp. engages in developing and manufacturing recombinant human and veterinary vaccines, therapeutics and diagnostics. The firm develops vaccines for influenza, SARS and other diseases. The company was founded by Mark A. Cochran and Franklin Volvovitz in 1983 and is headquartered in Meriden, CT.	Biotechnology	Cheryl Cohen	Director/Board Member
CLC Consulting LLC		Cheryl Cohen	Founder
ELEDON PHARMACEUTICALS, INC.	Pharmaceuticals: Major	Cheryl Cohen	Director/Board Member